Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis

BACKGROUND: To comparatively investigate the differential effect of second-line tumour necrosis factor inhibitors (TNFis) versus other biological agents on cardiovascular disease (CVD) risk-associated biomarkers in patients with rheumatoid arthritis (RA). METHODS: We evaluated the serum levels of li...

Descripción completa

Detalles Bibliográficos
Autores principales: Virone, Alexandre, Bastard, Jean-Philippe, Fellahi, Soraya, Capeau, Jacqueline, Rouanet, Stéphanie, Sibilia, Jean, Ravaud, Philippe, Berenbaum, Francis, Gottenberg, Jacques-Eric, Sellam, Jérémie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667971/
https://www.ncbi.nlm.nih.gov/pubmed/31413865
http://dx.doi.org/10.1136/rmdopen-2019-000897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667971/
https://www.ncbi.nlm.nih.gov/pubmed/31413865
http://dx.doi.org/10.1136/rmdopen-2019-000897

Ejemplares similares